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Hedgehog (Hh) signaling emerges as a potential pathway contributing to fat formation during postnatal 
development. In this report, we found that Patched 1 (Ptc1), a negative regulator of Hh signaling, was expressed in 
the epididymal fat pad of adult mice. Reduced total white fat mass and epididymal adipocyte cell size were 
observed in naturally occurring spontaneous mesenchymal dysplasia (mes) adult mice (Ptc1mes/mes), which carry a 
deletion of Ptc1 at the carboxyl-terminal cytoplasmic region. Increased expression of truncated Ptc1, Ptc2 and 
Gli1, the indicators of ectopic activation of Hh signaling, was observed in epididymal fat pads of adult Ptc1mes/mes 
mice. In contrast, expression of peroxisome proliferator-activated receptor gamma, CCAAT/enhancer binding protein 
alpha, adipocyte P2 and adipsin were reduced in epididymal fat pads of adult Ptc1mes/mes mice. Taken together, our 
results indicate that deletion of carboxyl-terminal tail of Ptc1 can lead to the reduction of white fat mass during 
postnatal development. 
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Introduction 
Hedgehog (Hh) signaling plays a critical role 
during embryonic development and tumorigenesis [1, 
2]. The canonical Hh signaling cascade is initiated 
through the binding of secreted Hh proteins to the 
membrane-bound receptor Patched-1 (Ptc1) or 
Patched-2 (Ptc2) to relieve patched-mediated 
repression of the signal transducer smoothened (Smo), 
leading to the activation of transcription factors Gli1, 
Gli2 and Gli3 to enhance transcription of downstream 
targets such as Ptc1, Ptc2 and Gli1 [1-5]. In addition to 
its critical roles during embryonic development and 
tumorigenesis, Hh signaling emerges as a potential 
mediator of fat formation and body weight gain 
during postnatal development [6, 7]. Injection of adult 
mice with sonic Hh (Shh)-IgG fusion protein (a Hh 
agonist) causes a significant increase in fat mass and 
body weight without affecting food consumption and 
fluid intake [8]. In agreement with this observation, 
inactivation of Hh signaling by injection of anti-Hh 
antibodies in normal adult mice fed with a high-fat 
diet and in obese leptin-deficient (ob/ob) mice fed with 
a low-fat diet can significantly reduce body weight 
gain in these animals [9]. These animal studies suggest 
that Hh signaling may stimulate fat formation 
(adipogenesis) and promote body weight gain in adult 
mice [8, 9]. In contrast to the above animal studies [8, 
9], it has been reported that Hh can block adipogenesis 
in cultured mammalian adipocytic or multipotent 
mesenchymal cells [10-13]. This is highlighted by the 
recent study by Suh et al [13]. They found that 
fat-body-specific activation of Hh signaling inhibited 
fat formation in Drosophila and that Hh blocked 
adipogenesis in mammalian cells by regulating 
antiadipogenic gene expression. In addition, they 
found that Hh signaling molecules such as Gli1, Gli2 
and Gli3 are expressed in white fat tissues (WAT) of 
adult mice and that expression of these genes are 
down-regulated in normal mice fed with high fat diet 
and in ob/ob  mice. A model of Hh signaling in 
inhibiting fat formation has been proposed in which 
Hh activates Gli transcription factors (Gli1, Gli2 and 
Gli3), which then activate antiadipogenic gene 
expression to inhibit the expression of adipogenic 
genes such as peroxisome proliferator-activated receptor 
gamma ( PPARgamma) [14, 15] and CCAAT/enhancer 
binding protein alpha  (CEBPalpha)  [16] in adipose 
tissues, resulting in inhibition of adipogenesis [6, 13]. 
According to this model, it is expected that ectopic 
activation of Hh signaling in adipose tissues will 
reduce fat formation in adults, which would be 
contradictory to observations reported by Martin et al 
[8]. Therefore, whether Hh signaling acts to stimulate 
or inhibit fat formation during postnatal development 
remains to be characterized in vivo using animal 
models such as mutant mice carrying deletions of Hh 
signaling molecules.  Int. J. Biol. Sci. 2008, 4 
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Ptc1 is a negative regulator of the Hh signaling 
during embryonic development [1, 4]. It is a Hh 
receptor protein containing twelve transmembrane 
domains and intracellular amino- and 
carboxyl-terminal regions [2, 17]. In the absence of Hh, 
Ptc1 represses Smo activity. This repression of Smo is 
relieved once after Hh binds to the extracellular loops 
within the transmembrane domains of Ptc1, resulting 
in the activation of Hh signaling downstream target 
genes to elicit its biological functions [2, 5, 17, 18]. It 
have been shown that the carboxyl terminus of Ptc1 is 
important for the inactivation of Hh signaling target 
genes and the localization and degradation of Ptc1 
itself [19, 20]. Deletion of Ptc1 in mice can mimic 
ectopic Hh signaling and cause embryonic lethality, 
indicating the essential role of Ptc1 during embryonic 
development [21]. Although Ptc1 has been shown to be 
a determinant of body weight in utero [21-23], there is 
no direct evidence that Ptc1 is also involved in 
controlling fat formation during postnatal 
development. The naturally occurring spontaneous 
mesenchymal dysplasia (mes) mouse line (Ptc1mes/mes), 
which has a deletion of the Ptc1 protein at the 
carboxyl-terminal cytoplasmic region and can bypass 
the embryonic lethality observed in a complete 
knockout of Ptc1 [22, 24], would be an excellent model 
to investigate the potential role of Ptc1 in fat formation 
during postnatal development. 
In this communication, we found that Ptc1 was 
expressed in epididymal white fat tissue (WAT) in 
adult mice. Loss of the carboxyl-terminus of Ptc1 in 
adult Ptc1mes/mes mice caused a significant reduction in 
WAT. The adipocyte size of epididymal WAT was also 
reduced in Ptc1mes/mes mice. Gene expression analyses 
showed that truncated Ptc1, Ptc2 and  Gli1  were 
overexpressed in WAT of Ptc1mes/mes mice, indicating 
ectopic activation of Hh signaling in WAT. Consistent 
with reduced WAT, expression of adipogenic genes, 
PPARgamma and CEBPalpha, and the adipocyte 
marker genes, adipocyte P2 (aP2) [25] and adipsin [26], 
were reduced in WAT of adult Ptc1mes/mes  males. 
Collectively, our results suggest that Ptc1 play a role in 
white fat formation during postnatal development. 
This study supports earlier findings of Suh et al and 
Spinella-Jaegle  et al that Hh signaling inhibits fat 
formation in cultured cells [10, 13]. 
Materials and Methods 
Animals and genotyping 
Ptc1mes/+  mice (B6C3Fe-a/a strain) were 
purchased from the Jackson Laboratory (Bar Harbor, 
Maine, USA) and maintained on a 14 hour light:10 
hour dark cycle, with free access to normal chow (Lab 
diet, Catalog #5001, USA) and water, in the vivarium 
of the University of Louisville. Ptc1+/+,  Ptc1mes/+ and 
Ptc1mes/mes littermates were obtained from the intercross 
of  Ptc1mes/+  mice and genotyped as previously 
described [22]. 
Tissue collection and body, tissue and total WAT 
weight analyses 
Mice at various ages were euthanized with 
carbon dioxide and the body weights of these mice 
were determined using an electronic balance. Liver, 
spleen, kidney, lung, heart and total WAT including 
subcutaneous, abdominal and intra-scapular fat in 
mice were collected and weighed using a balance. 
S i n c e  i t  t o o k  s o m e  t i m e  t o  c o l l e c t  W A T  f r o m  
subcutaneous regions of the whole animal which may 
damage the WAT histology and cause RNA 
degradation, WAT from epididymides were quickly 
harvested for histological and RNA analyses. 
Histological analysis of WAT and determination of 
WAT size 
Epididymal WAT was fixed in 4% 
paraformaldehyde, dehydrated and then embedded in 
paraffin. The paraffin-embedded tissues were 
sectioned at 7 μm thickness, stained with hematoxylin 
and eosin, and then examined under a microscope 
(Axioskop2, Zeiss, Thornwood, NY, USA). The 
average size of adipocyte cells from each mouse was 
determined by analyzing 40 randomly-selected 
adipocyte cells from 20 sections using the Zeiss 
Imaging Quantitative Software (Zeiss, Thornwood, 
NY, USA).  
RNA isolation and RT-PCR  
RNA was isolated from epididymal WAT of 
Ptc1mes/mes and control mice using Trizol reagent 
(Invitrogen, Carlsbad, CA, USA). First strand cDNA 
was synthesized at 42oC for 60 min using 1 μg of total 
RNA as template and random hexanucleotides as 
primers (Promega, Madison, WI, USA). PCR reactions 
with 1/10 of the cDNA were carried out in a buffer 
containing 1.5 mM MgCl2 (94oC, 1 min; 52oC, 1 min; 
72oC 1 min) for various numbers of PCR cycles (20-38 
cycles), which can detect the differential gene 
expression (within the linear range of PCR products 
for each gene). The nucleotide sequences of PCR 
primers are as follows: Ptc1 (Ptc1-F: 
5’-tgtctggcatcagtgaggag-3’, Ptc1-R: 5’-gacaaggagccaga 
gtccag-3’, 190 bp; Ptc1-F2: 5’-gctggaggagaacaagcaac-3’, 
Ptc1-R2: 5’-cattggggtagctggacagt-3’, 536 bp), Ptc2 
(5’-tgcctctctggagggcttcc-3’ and 5’-cagttcctcctgccagtgca 
-3’, 208 bp), Gli1 (5’-actggggtgagttcccttct-3’ and 
5’-tggcagggctctgactaact-3’, 492 bp), Gli2 
(5’-ccccctagcatcaatgagaa-3’ and 5’-tctgcacggattgtggatta 
-3’, 496 bp), Gli3 (5’-ctacggcgactgagaggaag-3’ and 5’- 
tggcatcaattggtacagga-3’, 396 bp), glucocorticoid-induced Int. J. Biol. Sci. 2008, 4 
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leucine-zipper protein ( Gilz, 5’-tggggcctagtaacaccaag-3’ 
and 5’-aagctgtaaccccacactgg-3’, 364 bp), CEBPalpha 
(5’-atcccagagggactggagtt-3’ and 5’-aagtcttagccggaggaa 
gc-3’, 373 bp), PARgamma (5’- ccctggcaaagcatttgtat-3’ 
and 5’-aatccttggccctctgagat-3’, 403 bp), aP2 (5’- 
tcacctggaagacagctcct-3’ and 5’-tcgactttccatcccacttc-3’, 
344 bp), adipsin (5’-caagcgatggtatgatgtgc-3’ and 
5’-atccggtaggatgacactcg-3’, 465 bp) and beta-actin 
(5’-ttgagaccttcaacacccc-3’ and 5’-agccagagcagtaatctcc- 
3’, 593 bp). All PCR products were confirmed by DNA 
sequencing.  
Food intake measurement 
Five adult wild type and Ptc1mes/mes mice at the age 
of 23-27 weeks were singly housed with free access to 
water. The food present in a sealed food hooper was 
recorded weekly for consecutive two weeks using an 
electronic balance.  
Glucose tolerance test 
Glucose tolerance test was performed as 
described previously [23]. Briefly, overnight-fasted 
24-26-week-old wild type, heterozygous and 
homozygous  Ptc1mes littermates were injected 
intraperitoneally with 2 grams/kg body weight of 20% 
D-glucose. Blood glucose levels at time 0 (immediately 
before the injection of glucose), 15, 30, 60, 120 and 180 
minutes after injection of glucose were determined 
using a Glucometer Elite glucometer.  
Statistical analysis 
When applicable, Student’s t-test was used to 
determine the statistical significance of difference 
between  Ptc1mes/mes and control littermates with P 
value less than 0.05. Data are presented as mean ± SEM 
of indicated numbers of mice in the figures.  
Results 
Expression of Hh signaling molecules Ptc1, Ptc2, 
Gli1, Gli2 and Gli3 in WAT of adult mice 
To determine whether Hh signaling molecules 
such as Ptc1, Ptc2, Gli1, Gli2 and Gli3 are expressed in 
WAT of adult mice, we performed RT-PCR analyses 
using specific primers for each gene. As shown in 
Figure 1, specific PCR products for those genes were 
detected in RNA samples from epididymal WAT of 
adult mice. In addition, we also observed the 
expression of an antiadipogenic gene Gilz  [27], 
adipogenic genes CEBPalpha and PPARgamma, and 
mature adipocyte marker genes aP2 and adipsin in 
epididymal WAT (Figure 1).   
 
Figure 1. Expression of Ptc1, Ptc2, Gli1 Gli2 and Gli3 in mouse 
epididymal WAT. Epididymal WAT RNA from 8-week-old 
mice was subjected to RT-PCR analyses using specific primers 
for  Ptc1  (Ptc1-F and Ptc1-R), Ptc2,  Gli1,  Gli2,  Gli3,  Gilz, 
PPARgamma, CEBPalpha, aP2 and adipsin. The numbers of 
PCR reaction cycles are 36 for Ptc1, 38 for Ptc2 and 32 for other 
tested genes. Water was included as negative controls.  
Reduced total WAT and adipocyte cell size in adult 
Ptc1
mes/mes mice 
To investigate if there is any defect in WAT 
during postnatal development, total WAT, body and 
major organ weights of male Ptc1+/+,  Ptc1mes/+ and 
Ptc1mes/mes littermates at various ages were determined 
(Figure 2). As shown in Figure 2a, total WAT weights 
were reduced in Ptc1mes/mes male mice during postnatal 
development with a modest reduction at the age of 
19-20 weeks and the remarkable reduction at the age of 
33 or 38 weeks, when compared to their wild type and 
heterozygous littermates (Figure 2a). No significant 
changes in body weights were observed between male 
Ptc1mes/mes  and control wild type and heterozygous 
littermates during postnatal development, except that 
19-20-week-old Ptc1mes/mes males were slightly heavier 
than their controls (Figure 2b). The ratios of total WAT 
to body weights were also significantly reduced in 
19-20-week-old or older Ptc1mes/mes males (Figure 2c). In 
contrast, there were no significant changes in gross 
weights of other tested organs including liver, spleen, 
kidney, lung and heart (Figure 2d). The representative 
results of reduced total WAT of 33-week-old Ptc1mes/mes 
male mice were shown in Figure 2e. Histological 
analyses showed that epididymal fat cells of these 
Ptc1mes/mes mice were smaller than those of Ptc1+/+ mice 
(Figure 2f). Quantitative analyses showed that the 
sizes of epididymal WAT cells in 33-week-old 
Ptc1mes/mes mice were significantly reduced (P < 0.01), 
when compared to those of Ptc1+/+ littermates (Figure 
2g).  Int. J. Biol. Sci. 2008, 4 
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Figure 2. Reduced total WAT and adipocyte cell sizes in adult male Ptc1
mes/mes mice, when compared to control Ptc1
+/+ littermates. 
a-d. Total WAT weights (a), body weights (b), the ratios of total WAT to body weights (c) and major organ weights (d) of Ptc1
+/+, 
Ptc1
mes/+ and Ptc1
mes/mes male mice during postnatal development. e. Representative photos showing reduced total WAT in Ptc1
mes/mes 
mice. Total WAT of two wild type and their Ptc1
mes/mes littermates at the age of 33 weeks are shown. f. Histology of WAT from 
33-week-old Ptc1
+/+ and Ptc1
mes/mes littermates. Note the small adipocyte cell size in WAT of Ptc1
mes/mes mice. g. Quantitative 
analyses showing the reduced cell size of WAT in 33-week-old Ptc1
mes/mes mice, when compared to their wild type littermates. In a-d 
and g, data are presented as mean ± SEM of the indicated numbers of mice in the bar graphs. *P < 0.05, **P < 0.01, when compared 
to Ptc1
+/+ and/or Ptc1
mes/+ littermates.  
 Int. J. Biol. Sci. 2008, 4 
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Enhanced expression of Hh signaling target genes 
(amino region of Ptc1, Ptc2, and Gli1) and reduced 
expression of adipogenic genes PPARgamma and 
CEBPalpha as well as adipocyte marker genes aP2 
and adipsin in epididymal WAT of adult Ptc1
mes/mes 
mice 
It has been reported that Ptc1mes  mutant mice 
carry a deletion of a 32 bp DNA fragment in the exon 
22 of Ptc1 allele [22] (Figure 3a). To confirm this, we 
isolated RNA from epididymal WAT of 8-10-week-old 
wild type and Ptc1mes/mes mice and performed RT-PCR 
analyses. As shown in Figure 3a, a positive DNA band 
covering exons 22 and 23 (using Ptc1-F and Ptc1-R 
primers) was detected in wild type, but not Ptc1mes/mes 
mice. These results confirmed the absence of the 
carboxyl-terminus of Ptc1 mRNA in epididymal WAT 
of Ptc1mes/mes mice. Since Ptc1 is a known downstream 
target gene of Hh signaling, RT-PCR analyses were 
also performed to determine whether expression of the 
amino region of the Ptc1 gene will be upregulated in 
epididymal WAT of Ptc1mes/mes mice. As shown Figure 
3a, positive DNA bands covering exons 15 and 18 of 
Ptc1  (using Ptc1-F2 and Ptc1-R2 primers) were 
detected in wild type mice and even more pronounced 
in  Ptc1mes/mes mice. Similar Ptc1 expression patterns 
were observed in epididymal WAT from 33-week-old 
mice (Figure 3b), indicating that the amino-terminal 
Ptc1 mRNA is overexpressed in WAT of Ptc1mes/mes 
mice.  
To determine whether there is mis-expression of 
other Hh signaling molecules and WAT marker genes 
in epididymal WAT, semi-quantitative RT-PCR 
analyses were performed on RNA samples isolated 
from 33-week-old Ptc1mes/mes mice. As shown in Figure 
3b, expression levels of the Hh signaling downstream 
target genes Ptc1,  Ptc2 and Gli1were increased in 
epididymal WAT of Ptc1mes/mes mice, when compared to 
those of Ptc1+/+ mice. Expression of Gli2, but not Gli3, 
was also increased in epididymal WAT of Ptc1mes/mes 
mice. In contrast, reduced expression of PPARgamma 
and  CEBPalpha, two known adipogenic genes, were 
observed in Ptc1mes/mes  mice, while there was no 
obvious change in the expression level of Gilz, an 
antiadipogenic gene [27], between Ptc1mes/mes  and 
Ptc1+/+  mice (Figure 3b). In addition, expression of 
WAT marker genes aP2 and adipsin were also reduced 
in Ptc1mes/mes mice (Figure 3b).  
 
Figure 3. Increased expression of Ptc1, Ptc2, Gli1 and Gli2 and reduced expression of PPARgamma, CEBPalpha, aP2 and adipsin 
in epididymal WAT of Ptc1
mes/mes mice. a. Representative RT-PCR analyses showing the loss of carboxyl-terminal Ptc1 mRNA 
(using Ptc1-F and Ptc1-R primers, 36 cycles) and increased expression of amino-terminal Ptc1 mRNA (using Ptc1-F2 and Ptc1-R2 
primers, 32 cycles) in WAT of two 8-10-week-old Ptc1
mes/mes mice. Deletion of 32 bp coding sequence within the exon 22 of Ptc1 in 
Ptc1
mes/mes mice is highlighted by a yellow box. Two sets of RT-PCR primers for Ptc1 mRNA are indicated by arrows. b. 
Representative semi-quantitative RT-PCR showing the increased expression of amino-terminal Ptc1, Ptc2, Gli1 and Gli2 and the 
reduced expression of PPARgamma, CEBPalpha, aP2 and adipsin in epididymal WAT of 33-week-old Ptc1
mes/mes mice. The 
numbers of PCR reaction cycles for carboxyl-terminal Ptc1 [Ptc1 (C): using primers Ptc1-F and Ptc1-R], amino-terminal Ptc1 
[Ptc1-(N):using primers Ptc1-F2 and Ptc1-R2], Ptc2, Gli1, Gli2, Gli3, Gilz, CEBPalpha, PPARgamma, aP2, adipsin and beta-actin 
were 36, 38, 38, 26, 26, 38, 36, 28, 28, 20, 20 and 32, respectively. Experiments were repeated twice on independent RNA samples. Int. J. Biol. Sci. 2008, 4 
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No significant changes in food consumption and 
glucose tolerance in adult Ptc1
mes/mes mice 
To determine if there is any difference in food 
consumption by Ptc1mes/mes  and their control Ptc1+/+ 
mice, we performed food intake experiments. As 
shown in Figure 4a, there was no statistically 
significant change in food consumption in either adult 
Ptc1mes/mes or Ptc1+/+ mice during the consecutive two 
weeks. The average food intake by adult Ptc1mes/mes 
mice at each tested week was also not significantly 
different from Ptc1+/+ control mice (Figure 4a). To test if 
there is any abnormality in serum glucose 
concentrations in adult Ptc1mes/mes  mice, glucose 
tolerance experiments were performed. As shown in 
Figure 4b, no statistical significance of difference in 
serum glucose concentrations among adult Ptc1+/+, 
Ptc1mes/+ and Ptc1mes/mes mice at each tested time point 
after the injections of high doses of glucose. 
 
Figure 4. No significant change in (a) food intake and (b) 
glucose tolerance between adult Ptc1
mes/mes and their control 
(Ptc1
+/+ or Ptc1
mes/+) mice. a. Food consumption by five adult 
wild type and Ptc1
mes/mes mice at the age of 23-27 weeks was 
recorded weekly for consecutive two weeks. b. 
Overnight-fasted 24-26-week-old littermates were subjected to 
glucose tolerance experiments as described in Materials and 
Methods. Data are presented as mean ± SEM of the indicated 
numbers of mice in the bar graphs. Student’s t-test was 
performed to determine the significant difference. P value was 
greater than 0.05 between Ptc1
mes/mes and controls (Ptc1
+/+ or 
Ptc1
mes/+) at each time point in the figure. 
Discussion  
In our ongoing study to determine the role of Ptc 
during ovarian and uterine development in Ptcmes/mes 
mice, we observed that total white fat masses in adult 
female  Ptcmes/mes mice were less than their wild type 
littermates (unpublished data). Since female Ptcmes/mes 
mice are being used to characterize their ovarian and 
uterine phenotypes, male Ptcmes/mes  and their control 
littermates were used to investigate the potential 
defects in WAT during postnatal development in this 
report. We found that Ptc1 was expressed in adult 
WAT and that loss of the carboxyl-terminus of Ptc1 in 
adult mice caused a significant reduction in total white 
fat mass and adipocyte cell size (Figure 1-2). Reduced 
white fat mass observed in adult Ptc1mes/mes mice can be 
due to the reduced cell sizes of adipocyte cells (Figure 
2) and the reduced adipocyte cell numbers in adult 
Ptc1mes/mes  mice. The latter is indicated by the 
observation that the reduced levels of adipose cell sizes 
(40% of controls) are less than the reduced levels of 
total WAT weights in 33-week-old Ptc1mes/mes (about 
75% of controls), even though it is difficult and almost 
impossible to determine the exact numbers of total 
adipocyte cells in adult mice. Since we did not observe 
significant changes in food intake and blood glucose 
concentrations in adult Ptc1mes/mes mice (Figure 4), the 
reduced white fat mass (reduced adipocyte cell size 
and cell numbers) is probably not due to reduced food 
consumption and aberrant glucose metabolism 
observed in Ptc1+/- mice [28] as well as other hormonal 
signaling such as insulin signaling during 
adipogenesis [29]. Rather, the reduced white fat mass 
is likely due to the defective Hh signaling during 
adipogenesis in Ptc1mes/mes  mice during postnatal 
development. By RT-PCR analyses, we found that 
many Hh signaling molecules are expressed in 
epididymal WAT (Figure 1), which is consistent with 
the presence of Gli transcription factors in perigonadal 
fat pads reported previously [13]. Importantly, we 
found that truncated Ptc1,  Ptc2  and  Gli1,  the  Hh 
signaling downstream target genes, are overexpressed 
in epididymal WAT of Ptc1mes/mes mice (Figure 3b), 
indicating the ectopic activation of Hh signaling in 
WAT to regulate its downstream gene expression for 
fat formation. Consistent with reduced white fat mass 
in Ptc1mes/mes mice, we also observed the reduced 
expression of adipocyte marker genes aP2 and adipsin. 
These reduced expression of adipocyte marker genes 
likely results from the decreased expression of 
adipogenic genes PPARgamma and CEBPalpha. It has 
been reported that Shh can inhibit adipocyte 
differentiation in 3T3-L1 cells, C3H10T1/2 and 
primary mouse calvaria cells [10, 13]. Overexpression 
of Gli1 and reduced expression of adipocyte markers, Int. J. Biol. Sci. 2008, 4 
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aP2 and/or adipsin, and adipogenic transcription 
factors,  PPARgamma  and  CEBPalpha,  have been 
observed in Shh-treated 3T3-L1 or C3H10T1/2 cells 
[10, 13]. Moreover, reduced expression of Gli1 and Gli2 
has been reported in ob/ob mice and normal mice fed 
with a high fat diet to induce obesity [13]. Collectively, 
our results are consistent with the recent findings from 
cultured cells [10, 13], indicating that Hh signaling 
plays a role in inhibiting WAT formation in adult mice.   
Since we did not observe overexpression of Gilz, 
an antiadipogenic gene, which has been reported by 
Suh et al in cultured cells [13], it is likely that the action 
of Hh signaling in adult white fat formation is via the 
inhibition of adipogenic gene transcription, rather than 
the stimulation of antiadipogenic gene expression. Our 
gene expression results indicate that Gli1 and Gli2, but 
not Gli3, may be two major transcription factors 
involved in adult WAT formation. These Gli 
transcription factors may inhibit transcription of 
adipogenic genes PPARgamma  and  CEBPalpha  in 
adipocyte cells, resulting in reduced WAT formation. 
Or, they could directly regulate adipocyte gene 
expression such as aP2 in WAT, given that Gli1 can 
inhibit aP2 promoter activity in C3H10T1/2 cells [10]. 
Future studies using molecular approaches such as 
gel-shift mobility and promoter reporter analyses will 
determine these possibilities. In addition, further 
molecular analyses of Hh signaling downstream genes 
in Hh agonist- or antagonist-treated 3T3-L1 cells 
over-expressing the amino region of Ptc1 (with a 
d e l e t i o n  o f  C - t e r m i n a l  r e s i d u e s  o f  P t c 1 )  o r  m o u s e  
embryonic fibroblast cells isolated from Ptc1mes/mes 
embryos will likely provide more details about the 
mechanism about the action of C-terminal tail of Ptc1 
during adipogenesis.   
We observed that there was a gradual reduction 
of total WAT in Ptc1mes/mes  males during postnatal 
development with no significant reduction of total 
WAT weights at the age of 5-6 weeks, modest 
reduction in 19-20-week-old mice and remarkable 
reduction in 33-week-old or older mice. This gradual 
reduction of WAT observed in our studies is 
contradictory to the previous finding of the increased 
adipose weights in Shh-treated mice [8]. One possible 
reason may be due to the differential expression levels 
of Hh target genes such as Ptc1, Ptc2 and Gli1 in white 
adipocyte cells in mice during postnatal development. 
Future gene expression analyses of Ptc1mes/mes mice at 
different developmental stages and Shh 
agonist-treated mice will be required to address this 
possibility.  
Increased body weights have been observed in 
Ptc1 mutant embryos [21-23] and Shh-treated normal 
mice [8]. Inhibition of body weight gain has also been 
reported in mice injected with antibodies against Hh 
proteins [9]. Ectopic activation of Hh signaling in 
Ptc1mes/mes mice would lead to general stimulation of 
cell proliferation (other than adipocyte cells), resulting 
in an increase of body weight. However, we did not 
observe a significant increase of the body weight in 
Ptc1mes/mes mice during postnatal development, except 
those mice at the age of 19-20 weeks after birth (Figure 
2). This phenomena is unlikely due to the reduction of 
food consumption as well as potential aberrant glucose 
metabolism displayed in Ptc1+/- mice [28], since food 
consumption and serum glucose levels in adult 
Ptc1mes/mes mice appears to be comparable with those of 
control littermates (Figure 4). Considering that the 
major organ weights including liver, heart, kidney, 
lung and spleen were not significantly different 
between Ptc1mes/mes and their control mice (Figure 2d), it 
is also unlikely the case that the general stimulation of 
cell proliferation by Hh signaling observed in embryos 
[22] plays a significant role in body weight gain during 
postnatal development. Instead, Hh signaling may be 
active only in a subset of target tissues such as WAT to 
elicit its biological function in adult Ptc1mes/mes  mice. 
Interestingly, Ptc1mes/mes mice at the age of 33 weeks or 
older were not lighter than their control littermates, 
even though there was a significant reduction of total 
white fat mass (Figure 2). In light of no significant 
changes in major organ weights in Ptc1mes/mes mice, it is 
possible that hyperplasia in other tissues and/or cells 
other than WAT and tested organs exist in Ptc1mes/mes 
mice, which may offset the reduced WAT weights. In 
support of this, we did notice that Ptc1mes/mes mice at 
that age appear to be rounder and bigger than their 
controls (unpublished data). Considering that 
activation of Hh signaling can push adipocyte 
precursor cells toward an osteogenic fate at the 
expense of adipogenesis [10-13, 30], it is likely that 
Ptc1mes/mes mice will display aberrant bone formation, 
which will affect the body weight during postnatal 
development. Recently, epidermal hyperplasia has 
been observed in adult Ptc1mes/mes mice [18], which will 
likely be another factor to offset the reduced WAT 
weight. Nevertheless, it appears that white fat mass is 
not a major factor that directly contributes to the body 
weight gain during postnatal development.  
In conclusion, we found that Ptc1 was expressed 
in the epididymal fat pad of adult mice. Reduced total 
white fat mass and white adipose cell size were 
observed in adult Ptc1mes/mes mice. Truncated Ptc1, Ptc2 
and  Gli1 were overexpressed in WAT of Ptc1mes/mes, 
suggesting ectopic activation of Hh signaling in WAT. 
Consistent with reduced WAT, expression of 
adipogenic genes, PPARgamma  and  CEBPalpha, and 
adipocyte marker genes, aP2 and adipsin, were reduced Int. J. Biol. Sci. 2008, 4 
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in WAT of adult Ptc1mes/mes mice. Our results suggest 
that deletion of the carboxyl terminal tail of Ptc1 can 
lead to a reduction of white fat mass during postnatal 
development. 
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